Market research
CPT.LSE Concepta PLC
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 10M
- P/E ratio
- Not available
- Analyst target
- 22
- Dividend yield
- 0.0%
- Beta
- 2.07
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- GB00BYZ2R301
- Market cap
- 10M
- P/E ratio
- Not available
- Analyst target
- 22
- Dividend yield
- 0.0%
- Beta
- 2.07
About
About Concepta PLC
Concepta PLC, a women's healthcare company, develops and commercializes mobile health diagnostics medical devices in the United Kingdom. Its products help women with unexplained infertility to concieve. The company offers MYLO, a home-use personalized fertility tracking and pregnancy self-testing system. MYLO allows quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone during ovulation and human chorionic gonadotropin hormone level during pregnancy, facilitating conception rates and early diagnosis of fertility issues. The company was formerly known as Frontier Resources International PLC. Concepta PLC was incorporated in 2008 and is based in Cardiff, the United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the CPT.LSE discussion.
5 years, 5 months ago
Concepta PLC is currently in a long term uptrend where the price is trading 52.6% above its 200 day moving average.
From a valuation standpoint, the stock is 58.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 184.0.
Based on the above factors, Concepta PLC gets an overall score of 2/5.